
Results
3
3 companies
Kuros Biosciences
Market Cap: CHF 653.0m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 16.46
7D
-9.7%
1Y
-29.4%
MindMaze Therapeutics Holding
Market Cap: CHF 25.2m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.15
7D
-11.7%
1Y
n/a
Cosmo
Market Cap: CHF 940.3m
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
CMHC
CHF 54.70
7D
-0.2%
1Y
-18.5%